Q: What is Ultram? A: Ultram is a prescription-only synthetic pain relief medicine intended for people with moderate to moderately severe chronic pain. Ultram, manufactured by Ortho McNeil, is the brand...
Q: What is Tramadol? A: Tramadol (tramadol hydrochloride) is a prescription-only synthetic pain relief medicine intended for people with moderate to moderately severe pain. Tramadol tablets are often prescribed...
I. General Pain Relief FAQ Q: What is pain and why do we need it? A: Pain is the body's warning system alerting you that something is wrong. Without pain, serious life-threatening injuries or diseases...
We all experience pain. Pain can be mild, moderate or severe. Some pain is chronic, some is periodic. What we all have in common is that we want the discomfort to end. And finding a pain relief medication...
Q : What is Butalbital? A: Butalbital is a barbiturate class drug that acts as a muscle relaxant and is often prescribed for the treatment of headaches and other moderate level pain that may not respond...
At one time or another, every one of us suffers from some sort of pain. But very few of us take the time to learn about the causes of our pain and the many different pain relief drugs and techniques to...
The term "arthritis" refers generally to an inflammation of the joints and is typically associated with stiffness and joint pain. The different forms of arthritis vary in terms of cause, severity...
Good question, one that's probably been asked by everyone who's ever sought pain relief from a doctor and been prescribed a pain reliever with caffeine such as Butalbital, Acetaminophen and Caffeine (Fioricet...
If you’re thinking about taking Butalbital to help ease your tension headaches or provide some other kind of pain relief, you likely have questions about how it works, how to take it safely, drug...
Back pain is reported to be the most common cause of missed work, right after flu and colds. In fact, back pain is so common that many people consider it inevitable, especially with increasing age. But...
Subscribe in a reader
